Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.

<h4>Objective</h4>To describe the profile of patients with multiple sclerosis (MS) treated with fingolimod in Spain and to assess the effectiveness and safety of fingolimod after 4 years of inclusion in the Spanish Gilenya Registry.<h4>Methods</h4>An observational, retrospect...

Full description

Saved in:

Bibliographic Details
Main Authors:	J E Meca-Lallana, C Oreja-Guevara, D Muñoz, J Olascoaga, A Pato, L Ramió-Torrentà, V Meca-Lallana, M A Hernández, M E Marzo, J C Álvarez-Cermeño, A Rodríguez-Antigüedad, X Montalbán, O Fernández, Spanish GILENYA Registry Investigators
Format:	article
Language:	EN
Published:	Public Library of Science (PLoS) 2021
Subjects:	Medicine R Science Q
Online Access:	https://doaj.org/article/07987836f8b74fd78ad563e5d9b47c6e
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.

Similar Items